Contraceptive use and uptake Hasinah Asmal, Samantha Govender, Ian Naicker, Dinesh Singh, Gita Ramjee.

Slides:

Advertisements

Similar presentations

Integrating Family Planning Services into an STD Clinic Setting Judith Shlay, MD, MSPH Denver Public Health Denver, CO.

Advertisements

Sexual behaviour Additional module for inclusion in countries where HIV/AIDS is a potential concern (includes MDG indicator 19a) Womens questionnaire (ages.

What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.

Integrating Family Planning Services into an STD Clinic Setting J. Shlay, D. Bell, M. Maravi, C. Urbina, and the entire Denver Metro Health Clinic Staff.

LIFE CYCLE APPROACH. life cycle approach ( 2 ) Anticipates and meets women’s health needs from infancy through old age Emphasizes health-seeking behavior.

Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.

Demand for family planning among postpartum women attending integrated HIV and postnatal services in Swaziland Charlotte Warren, Timothy Abuya, Ian Askew,

To test the effectiveness of new HIV-prevention methods like microbicides, late-stage trials must enroll large numbers of sexually active women. Current.

Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.

Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.

Uptake of HIV Related Care Among Seroconvertors— Implications for VOICE or future HIV prevention trials Sharika Gappoo*, Sarita Naidoo, Yuki Sookrajh,

HIV and Reproductive Health? William Stones. Questions What is reproductive health? Is HIV best approached as a RH topic? What are the pros and cons of.

Session II, Slide 1 Standard Days Method (SDM) Session II: Who Can and Cannot Use SDM.

Forming and Sustaining Community Groups / Community Advisory boards (CWGs/CABs) Presenter: Smangaliso Ntshele Community Mobilization Project Leader, Medical.

STD Testing Protocols, STD Testing, and Discussion of Sexual Behaviors in HIV Clinics in Los Angeles County Melanie M. Taylor MD, MPH Los Angeles County.

V.N.Prilepskaya, А.А.Kuzemin, Т.А.Nazarenko, Т.М.Astahova Research Centre of Obstetrics, Gynecology & Perinatology, Moscow Mifepriston in emergency contraception.

Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,

1 Regulatory Concepts for Dual Indication Combination Products Charu Mullick, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration.

July 24, 2012 GENDER ROLES, EQUALITY AND TRANSFORMATIONS PROJECT INSTITUTE FOR REPRODUCTIVE HEALTH GEORGETOWN UNIVERSITY PATHFINDER INTERNATIONAL SAVE.

Sexually Transmitted Infections. What is a Sexually Transmitted Infection or STI? STI’s are infections that are spread from person to person through.

RATIONALE FOR INVOLVING MEN IN FAMILY PLANNING Irina Savelieva, MD, PhD Research Centre of Obstetrics, Gynecology and Perinatology, Russian Society of.

PREVALENCE OF ANAEMIA IN WOMEN AT SCREENING AND FOLLOW-UP IN A MICROBICIDE PHASE III TRIAL Hasinah Asmal, Dinesh Singh, Gita Ramjee HIV Prevention Research.

Embedding Open-label PrEP trial in expansion of UK HIV Prevention Programme.

XIX International AIDS Conference

Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.

TEMPLATE DESIGN © Improvements of sexual and reproductive healthcare needs of women with HIV in primary care setting W.

Repeat Pregnancy in HIV Positive Indian Women Nishi Suryavanshi 1 Ashwini Erande 1, Hemlata Pisal 1, Anita V. Shankar 2, Robert C. Bollinger 3, Mrudula.

MDP301 An international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5.

Will Your Partner Be Attending? Involving men in the prevention of mother to child transmission of HIV in antenatal care clinics in Iringa, Tanzania Kikumbih.

Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.

Mixed methods in medical research Robert Pool Centre for International Health, Hospital Clinic, University of Barcelona London School of Hygiene & Tropical.

Providing Comprehensive Reproductive Health Services for Men Visiting Clinics for Sexually Transmitted Infections Kees Rietmeijer, MD, PhD, MSPH Colorado.

Measuring Adherence in Microbicide Trials Robert Pool Centre For International Health Research WHO-ICMR-CONRAD-IPM Meeting on Regulatory Issues in Microbicide.

| > Alzheimer’s disease is fast becoming one the greatest medial challenges facing American’s today  6 th leading cause.

National Center for Health Statistics DCC CENTERS FOR DISEASE CONTROL AND PREVENTION Women’s Health Data in the National Survey of Family Growth (NSFG)

Sterilisation uptake in the Dominican Republic: are women begging for it? Tiziana Leone Department of Social Policy.

Routine Opt-Out HIV Testing Texas STD Clinics James H. Lee, Senior Public Health Advisor HIV/STD Program Texas Department of State Health Services.

The Big Picture: Trends In Protective Behaviour Among Young Women John Cleland.

Sexual and Reproductive Health in Adolescent Female Sex Workers: Kunming, China Xu-Dong Zhang M.Sc International Centre for Reproductive.

Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.

1 PREVENTION RESEARCH ADVOCACY COMMUNITY PREPAREDNESS IN HIV PREVENTION TRIALS AND USE OF EXISTING METHODOLOGIES MDP 301 trial in Mwanza, Tanzania Charles.

August 20, 2003FDA Antiviral Drugs Advisory Committee Meeting 1 Statistical Considerations for Topical Microbicide Phase 2 and 3 Trial Designs: A Regulatory.

Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.

Contraception/Pregnancies. Why do we care? Participants must come off product during pregnancy and breastfeeding Time off product results in dilution.

The Prevalence of Chlamydia Infection in Youth Offenders in HMP/YOI Holloway June 2003 – June 2005 THERESA BURNS, SEXUAL HEALTH ADVISER Women’s Health.

Considerations for Topical Microbicide Phase 3 Trial Designs, an Investigator’s Perspective Andrew Nunn Medical Research Council Clinical Trials Unit London,

AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000 GELS FOR.

Family Planning In Jordan

R EPRODUCTIVE HEALTH RELATED DATA FROM ICAP- SUPPORTED PROGRAMS Annual survey of HIV care and treatment facilities Pilot of a family planning screening.

Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to Reproductive Health Research II William A. Fisher, Ph.D Department.

Medico-economical aspects of post-abortion contraception Elena Grigorjeva, MD, Ph.D Regional Department Mother& Child Health, Altay Kray.

Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.

XVII Annual International AIDS Conference SHAZ! Shaping the Health of Adolescents in Zimbabwe Mudekunye, S. Laver University of Zimbabwe-University of.

Factors contributing to diaphragm size change in a Clinical Trial HIV PREVENTION RESEARCH UNIT Govender SM; Mtungwa LN; Manarsingh F; Naidoo VH; Ramjee.

Customers health literacy on health check-up services and primary health care providers attitudes Dulamsuren Samdan, MD,MPH,PhD President, “New Public.

Adesina OA*, Awolude O, Oladokun A, Roberts A, Adewole IF, Department of Obstetrics & Gynaecology, College of Medicine, University of Ibadan. *Corresponding.

Impact of level of researcher support on coital diary results and acceptability among women at high risk of HIV in the Microbicides Development Programme.

Microbicides: New Hope for Prevention of HIV and other STIs Your name here

What is HIV research telling us about women’s sexuality? Exploring the construction of sexuality during the Phase III clinical trial of a microbicide gel.

Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.

Co-Authors: Ndifreke M. SOCIETY FOR FAMILY HEALTH

MTN-036 Study of Extended Duration Dapivirine Vaginal Ring for HIV Prevention How do I know if I’m Eligible to join? Women who join the study must.

MULTIPURPOSE PREVENTION TECHNOLOGY (MPT) PRODUCT PIPELINE & THEIR POTENTIAL ACCEPTABILITY AMONG ADOLESCENT GIRLS & YOUNG WOMEN Barbara Friedland, Population.

Stephen Okoboi TASO Uganda Ltd

Are condoms a contraceptive method

Integrated youth-friendly health services lead to substantial improvements in uptake of HIV testing, condoms, and hormonal contraception among adolescent.

Provider Attitudes Regarding Varicella Vaccine Objective

Presentation transcript:

Contraceptive use and uptake Hasinah Asmal, Samantha Govender, Ian Naicker, Dinesh Singh, Gita Ramjee

BACKGROUND MDP 301 is a phase III clinical trial testing the efficacy and safety of 0.5% and 2% PRO 2000/5 vaginal microbicides in preventing HIV infection. High pregnancy rates continue to pose a challenge impacting on the power of study to show efficacy.

OBJECTIVES To determine reasons for lack of contraceptive use among women of reproductive age.

METHODOLOGY Contraception data collected during sexual behaviour interviews was analysed. This was a retrospective review of the sexual behaviour interviews of the first 1007 eligible women screened.

Methods of Contraception

RESULTS N = 1007 Eligible women at screening 51 % n = 514 Hormonal Contraception 49 % n = 493 Not on Hormonal Contraception 20 % n = 201 NOT on any contraception 29 % n = 292 Condoms ONLY REASONS : See Graph

OTHER included the following : Partner opposition Parental Opposition Hypertension Religious reasons Assumption partner is infertile Previous pregnancy whilst on contraception

CONCLUSIONS 49% of participants are not on hormonal/reliable contraception. Side effects are a common concern for participants. A significant percentage of participants provided no reason for lack of contraception use or admitted to not having given it much thought. Insufficient family planning education is available to women in our communities. HIV prevention trials should invest in family planning issues to ensure safety of participants and minimal drop outs. Hormonal contraceptives with low side effect profiles eg. the hormonal patch and new generation oral contraceptives should be made available. Quality of care is important in ensuring women make informed decisions that they will be able to adhere to. In the first few months after initiation of a new contraceptive method, regular clinic visits are important as some side effects may appear more severe early on and influence a participant’s decision to discontinue the method. Field education visits can increase community awareness of family planning and address common myths.

ACKNOWLEDGEMENTS Research Participants Medical Research Council MDP (Microbicide Development Programme) DFID (Department for International Development)

Contact Information Hasinah Asmal HIV Prevention Research Unit Medical Research Council Tel. +27 (0)